GLP-1 Savings Cards vs Self-Pay: What to Check
A GLP-1 savings card and a self-pay price are not necessarily the same thing — even when both come from the manufacturer.
The easiest way to tell them apart is to ask:
Is this prescription being processed through my insurance, or am I paying outside insurance?
That answer matters because it can change your price and whether the payment counts toward your deductible or out-of-pocket limit.
How does a commercial savings card work?
A manufacturer savings card can reduce what an eligible commercially insured patient owes after insurance processes the prescription.
For example, Lilly currently says eligible commercially insured patients with coverage for Foundayo may pay as little as $25 per month, subject to program limits and terms.
Novo Nordisk also offers savings programs for products including Wegovy and Ozempic.
But "as little as $25" does not mean the drug universally costs $25. Eligibility, insurance coverage and savings limits apply.
Government program beneficiaries are commonly excluded from commercial copay-card offers.
What is self-pay?
Self-pay means the prescription is bought outside the normal insurance claim.
Manufacturer programs now make this much easier. Current examples include:
- Foundayo starting around $149/month
- Wegovy pill starting around $149/month
- Wegovy injection starting around $199/month for certain new-patient starter fills
- Zepbound starting around $299/month
- Ozempic starting around $199/month for certain new-patient starter fills
- Mounjaro starting around $499/month
Dose and program terms matter.
One confusing detail: manufacturers sometimes use a "self-pay savings card" to deliver the cash price. So the word "card" alone does not tell you whether insurance is involved.
Read the terms or ask the pharmacy whether the claim is being processed through your plan.
Will a self-pay GLP-1 count toward my deductible?
Do not assume it will.
NovoCare explicitly says money spent when you choose to self-pay outside insurance does not count toward your out-of-pocket limits or deductible.
Lilly's Foundayo self-pay terms similarly state that patients using the self-pay program agree not to apply those costs toward deductible or true out-of-pocket requirements.
For your own plan, ask before paying:
"If I buy this prescription outside insurance, can I submit it for deductible or out-of-pocket credit?"
What if the cash price is lower than my insurance price?
Compare today's savings with the insurance tradeoff.
Hypothetical example: Your insurance patient responsibility is $425. A manufacturer self-pay price is $349.
Cash saves $76 today.
But if the $425 insurance payment would count toward your deductible and the $349 cash purchase would not, the annual difference could be more complicated.
There is no universal winner. The right comparison is:
Price today + effect on your insurance benefits.
What should Medicare patients do?
Check Medicare before using a commercial savings card or paying manufacturer cash.
Commercial manufacturer savings cards generally exclude people enrolled in federal healthcare programs.
More importantly, 2026 created a new option: eligible Medicare Part D beneficiaries can get certain Foundayo, Wegovy and Zepbound prescriptions for $50 per month through the Medicare GLP-1 Bridge. Other GLP-1 prescriptions may belong under regular Part D when used for a Part D-coverable indication.
Read Does insurance cover GLP-1s in 2026? before choosing a cash route.
What should I compare at the pharmacy?
Ask for these three prices:
- Insurance: "What is my patient responsibility if you run this through my plan?"
- Manufacturer: "Is there a savings or self-pay program for my exact drug and dose?"
- Cash: "What is the pharmacy cash price if I do not use insurance?"
Then ask:
"Which of these options counts toward my deductible or out-of-pocket maximum?"
That is usually more useful than asking which price is simply "cheapest."
Bottom line
A copay, manufacturer savings price and self-pay price are three different things.
The lowest number may be obvious. The lowest total-cost choice may not be.
Compare the price, eligibility rules and insurance impact before you pay.
Unblind Health provides general healthcare pricing and coverage information for educational purposes. Prices, eligibility, coverage and program terms vary and can change; confirm current information with your plan, pharmacy or the manufacturer before you pay. Never start, stop, switch or change the dose of a medication based on price alone. Talk with your prescriber or pharmacist about medication decisions. This is not medical, legal, tax or insurance advice.
Sources
- Lilly — Foundayo coverage and savings — checked September 11, 2026
- Lilly — Zepbound savings and insurance — checked September 11, 2026
- NovoCare — Wegovy cost, coverage and savings — checked September 11, 2026
- NovoCare Pharmacy — Terms — checked September 11, 2026
- Medicare.gov — Weight loss drugs / Medicare GLP-1 Bridge — checked September 11, 2026